Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health

Simple item page
dc.citation.firstpage484
dc.citation.issueNumber4
dc.citation.journalTitleJournal of Infection and Public Health
dc.citation.lastpage494
dc.citation.volumeNumber14
dc.contributor.authorRafferty, Megan S.
dc.contributor.authorBurrows, Hannah
dc.contributor.authorJoseph, Jake P.
dc.contributor.authorLeveille, Jennifer
dc.contributor.authorNihtianova, Snejana
dc.contributor.authorAmirian, E. Susan
dc.contributor.orgPublic Health & Healthcare Program, Texas Policy Lab
dc.date.accessioned2021-03-23T16:26:56Z
dc.date.available2021-03-23T16:26:56Z
dc.date.issued2021
dc.description.abstractThe coronavirus disease 2019 (COVID-19) pandemic has caused widespread mortality and morbidity. Though children are largely spared from severe illness, a novel childhood hyperinflammatory syndrome presumed to be associated with and subsequent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has emerged with potentially severe outcomes. Multisystem inflammatory disorder in children (MIS-C) most commonly affects young, school-aged children and is characterized by persistent fever, systemic hyperinflammation, and multisystem organ dysfunction. While uncommon and generally treatable, MIS-C presents potentially life-altering medical sequelae, complicated by a dearth of information regarding its etiology, pathophysiology, and long-term outcomes. The severity of MIS-C may warrant the need for increased awareness and continued COVID-19 mitigation efforts, particularly until potential factors conferring a predisposition to MIS-C can be clarified through additional research. Well-informed guidelines will be critical as the school year progresses. In this article, current knowledge on MIS-C is reviewed and the potential implications of this novel syndrome are discussed from a public health perspective.
dc.identifier.citationRafferty, Megan S., Burrows, Hannah, Joseph, Jake P., et al.. "Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health." <i>Journal of Infection and Public Health,</i> 14, no. 4 (2021) Elsevier: 484-494. https://doi.org/10.1016/j.jiph.2021.01.008.
dc.identifier.doihttps://doi.org/10.1016/j.jiph.2021.01.008
dc.identifier.urihttps://hdl.handle.net/1911/110186
dc.language.isoeng
dc.publisherElsevier
dc.rightsThis is an open access article under the CC BY-NC-ND license
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.keywordMultisystem inflammatory disorder in children;Pediatric inflammatory multisystem syndrome;Coronavirus;MIS-C;PIMS;COVID-19
dc.titleMultisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2-0-S1876034121000125-main.pdf
Size:
351.8 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Rice Coronavirus Research